Treatment for primary biliary cholangitis
AssigneeCadila Healthcare Limited
InventorsMukul R. Jain, Deven V. Parmar, Suresh Giri, Binu Philip, Pankaj Patel
Life of this patent
Estimating the term…
Abstract
The present invention provides therapeutic compound for prevention and treatment of primary biliary cholangitis, (PBC). Specifically, the present invention provides pharmaceutical composition comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof, for the treatment of PBC.
Claims10
A method of treating primary biliary cholangitis, comprising administering orally and once daily to a human in need thereof about 2 mg or about 4 mg of saroglitazar magnesium salt, to treat the primary biliary cholangitis;
- wherein saroglitazar is represented by:
A method of treating primary biliary cholangitis, comprising administering orally and once daily to a human in need thereof a pharmaceutical formulation in the form of a tablet or a capsule, the pharmaceutical formulation comprising about 2 mg or about 4 mg of saroglitazar magnesium salt;
- and a pharmaceutical excipient, to treat the primary biliary cholangitis;
- wherein saroglitazar is represented by:
Dependencies are inferred from the claim text.